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lian	 cell	 membranes.	 These	 membrane	 pores	 enable	 the	 delivery	 of	 virulence	
factors	 into	 cells,	 result	 in	 the	 leakage	 of	 molecules	 that	 bacteria	 can	 use	 as	
nutrients,	 and	 facilitate	 pathogen	 invasion.	 Inflammatory	 responses	 to	 bacte-
ria	 are	 regulated	 by	 the	 side-	chain-	hydroxycholesterols	 27- hydroxycholesterol	
and	 25- hydroxycholesterol,	 but	 their	 effect	 on	 the	 intrinsic	 protection	 of	 cells	
against	 pore-	forming	 toxins	 is	 unclear.	 Here,	 we	 tested	 the	 hypothesis	 that	
27- hydroxycholesterol	 and	 25- hydroxycholesterol	 help	 protect	 cells	 against	
pore-	forming	toxins.	We	treated	bovine	endometrial	epithelial	and	stromal	cells	
with	 27- hydroxycholesterol	 or	 25- hydroxycholesterol,	 and	 then	 challenged	 the	
cells	with	pyolysin,	which	is	a	cholesterol-	dependent	cytolysin	from	Trueperella 
pyogenes	 that	 targets	 these	 endometrial	 cells.	 We	 found	 that	 treatment	 with	








and	25- hydroxycholesterol	 in	uterine	and	follicular	 fluid.	Furthermore,	epithe-
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1 	 | 	 INTRODUCTION





















forming	 toxins,	 cholesterol-	dependent	 cytolysins.7,9,11	
Cholesterol-	dependent	cytolysins	bind	cholesterol	in	cell	
membranes,	 which	 is	 accessible	 when	 membrane	 lipids	
comprise	>35 mol%	cholesterol.12–	14	Pyolysin	 is	 secreted	
as	a	55 kDa	monomer	and	30	to	50	molecules	oligomerize	












Whilst	 repair	 encompasses	 replacing	 or	 fixing	 dam-
aged,	 worn,	 or	 faulty	 structures,	 protection	 implies	 de-
fending	 or	 guarding	 against	 attack,	 injury,	 or	 damage.	
Cell	membranes	most	obviously	need	protection	against	
pore-	forming	 toxins.	Cell	membrane	cholesterol	homeo-
stasis	 is	 controlled	 by	 several	 mechanisms,	 including	
the	 action	 of	 side-	chain-	hydroxycholesterols,	 such	 as	
27-	hydroxycholesterol	 and	 25-	hydroxycholesterol.24,25	
These	 oxysterols	 act	 via	 liver	 X	 receptor	 transcription	
factors,	LXRα	(encoded	by	NR1H3)	and	LXRβ	(NR1H2),	
which	 are	 both	 expressed	 in	 the	 ovary	 and	 uterus,25,26	
and	 by	 activating	 acetyl-	CoA	 acetyltransferase	 (ACAT)	
to	 catalyze	 cholesterol	 esterification.27,28	 However,	 side-	
chain-	hydroxycholesterols	 also	 regulate	 immunity	 and	




and	 25- hydroxycholesterol	 help	 protect	 cells	 against	
pore-	forming	 toxins.	 We	 treated	 bovine	 endometrial	 ep-
ithelial	 and	 stromal	 cells	 with	 27-	hydroxycholesterol	 or	
25-	hydroxycholesterol,	 and	 then	 challenged	 the	 cells	 with	
pyolysin.	 We	 used	 pyolysin	 because	 T. pyogenes	 is	 a	 uter-
ine	 pathogen	 and	 pyolysin	 damages	 endometrial	 cells.9,10,18	
Cytoprotection	 was	 assessed	 by	 measuring	 the	 pyolysin-	
induced	 leakage	 of	 potassium	 ions	 and	 LDH	 into	 cell	 su-
pernatants,	and	by	evaluating	cell	viability	or	changes	in	the	
cytoskeleton.	We	 explored	 whether	 oxysterol	 cytoprotection	
was	mediated	via	changes	in	cholesterol	or	depended	on	LXRs	
or	ACAT.	 In	addition,	we	examined	whether	 the	oxysterols	
also	 protected	 against	 α-	hemolysin	 from	 the	 endometrial	
pathogen,	S. aureus.8	Finally,	we	measured	the	abundance	of	
oxysterols	in	samples	from	the	bovine	reproductive	tract.






house,	 and	 uteri	 were	 collected	 with	 approval	 from	 the	
United	Kingdom	Department	for	Environment,	Food	and	
Rural	 Affairs	 under	 the	 animal	 by-	products	 regulation	
(EC)	No.	1069/2009	(registration	number	U1268379/ABP/
OTHER).
2.2	 |	 Cell culture
Endometrial	 epithelial	 and	 stromal	 cells	 were	 isolated	
from	 uteri,	 cell	 purity	 confirmed,	 and	 absence	 of	 im-
mune	 cell	 contamination	 verified,	 as	 described	 previ-
ously.17,31	 Briefly,	 following	 enzymatic	 digestion	 of	 the	
K E Y W O R D S
cattle,	cholesterol,	cytoprotection,	liver	X	receptor,	uterus
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endometrium,	 the	 cell	 suspension	 was	 sieved	 through	




Gloucester,	 UK),	 at	 37.5°C	 in	 humidified	 air	 contain-
ing	5%	carbon	dioxide,	 in	complete	medium	comprising	
RPMI-	1640	 medium	 (Thermo	 Fisher	 Scientific,	 Paisley,	
UK),	10%	fetal	bovine	serum	(Biosera,	East	Sussex,	UK),	
and	 1%	 antibiotic	 and	 antimycotic	 solution	 (Merck,	
Gillingham,	UK).	Culture	media	were	replenished	every	
48	to	72 h,	and	5 × 104	passage	1	or	2	cells	seeded	in	1 ml/




2.3	 |	 Pore- forming toxins
The	 plo	 plasmid	 (pGS59)	 was	 a	 gift	 from	 Dr  H	 Jost	
(University	 of	 Arizona,	 USA).	 Pyolysin,	 with	 an	 activity	
of	628,338	hemolytic	units	(HU)/mg	protein,	was	gener-




2.4	 |	 Cytoprotection experiments
The	 amount	 of	 pyolysin	 required	 to	 damage	 endome-
trial	 cells	 was	 determined	 by	 culturing	 cells	 for	 24  h	 in	








tion,	 whereas	 a	 longer	 challenge	 might	 also	 reflect	 cell	
repair	 and	 replication.	 At	 the	 end	 of	 the	 challenge	 pe-
riod,	 pyolysin-	induced	 pore	 formation	 was	 evaluated	 by	
measuring	the	leakage	of	LDH	into	cell	supernatants,	and	
cytolysis	 was	 evaluated	 using	 MTT	 assays,	 as	 described	
previously.17
To	 examine	 whether	 oxysterols,	 steroids	 that	 regu-
late	 endometrial	 function,	 or	 synthetic	 LXR	 agonists	
protected	 cells	 against	 pyolysin,	 stromal	 and	 epithe-
lial	 cells	 were	 treated	 in	 serum-	free	 medium	 contain-
ing	 vehicle	 or	 the	 range	 of	 concentrations	 specified	 in	
Results	 of	27-	hydroxycholesterol,	 25-	hydroxycholesterol,	






2  ±  3  ng/ml	 25-	hydroxycholesterol	 in	 human	 plasma.33	
Steroid	 concentrations	 spanned	 and	 exceeded	 physio-




25-	hydroxycholesterol,	 7β-	hydroxycholesterol	 and	 7α-	
hydroxycholesterol;	 ethanol	 for	 hydrocortisone,	 pro-
gesterone,	 and	 estradiol;	 dimethyl	 sulfoxide	 (DMSO)	
for	 T0901317	 and	 GW3965;	 and,	 water	 for	 methyl-	β-	
cyclodextrin.	 Cells	 were	 treated	 for	 24  h,	 based	 on	 pre-
vious	cytoprotection	studies32,38;	except	when	evaluating	








sin	 binds	 directly	 to	 treatments,	 pyolysin	 was	 mixed	
with	 serum-	free	 medium	 containing	 vehicle,	 25  ng/ml	
27-	hydroxycholesterol,	 5  ng/ml	 25-	hydroxycholesterol,	
25 nM	T0901317,	125 nM	GW3965,	or	0.5 mM	methyl-	β-	
cyclodextrin	and	then	used	to	challenge	cells	for	2 h.	At	
the	end	of	 the	challenge	period,	 cell	 supernatants	were	




To	 examine	 the	 role	 of	 ACAT	 in	 cytoprotection,	 we	
used	 the	 selective	ACAT	 inhibitor	Sandoz	58-	035	 (SZ58-	
035,	 Merck).39	 Stromal	 and	 epithelial	 cells,	 70%	 conflu-
ent	 in	 24-	well	 culture	 plates,	 were	 washed	 twice	 with	
phosphate-	buffered	saline	(PBS,	Merck)	and	treated	with	
DMSO	vehicle	or	10 µM	SZ58-	035	 in	serum-	free	culture	
medium	 for	 16  h,	 as	 described	 previously.28	 The	 cells	




27-	hydroxycholesterol	 can	 activate	 the	 estrogen	 recep-
tor	we	examined	 the	 role	of	 the	estrogen	 receptor	using	
the	 estrogen	 receptor	 antagonists	 ICI	 182,780	 (Tocris)	
and	MPP	dihydrochloride	(Tocris),40	as	described	for	the	
ACAT	 inhibitor,	 except	 that	 we	 cultured	 the	 cells	 with	
DMSO	 vehicle	 or	 the	 range	 of	 concentrations	 specified	
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in	 Results	 of	 ICI	 182,780	 or	 MPP	 dihydrochloride	 for	
1 h,	and	 then	 treated	 the	cells	with	vehicle	or	25 ng/ml	
27-	hydroxycholesterol	 for	 24  h	 in	 combination	 with	 ve-
hicle,	 ICI	 182,780	 or	 MPP	 dihydrochloride,	 followed	 by	










get	 NR1H3	 (sense,	 GCUAAAUGAUGCUGAGUUUUU;	
antisense,	 AAACUCAGCAUCAUUUAGC)	 or	 NR1H2	
(sense,	 AGGUGAAGGUGUCCAGUUAUU;	 anti-
sense,	 UAACUGGACACCUUCACCU).32	 A	 mixture	 of	
20 pmol	siRNA,	100 µl	Opti-	MEM	1	medium	and	1.5 µl	





treated	 with	 vehicle,	 25  ng/ml	 27-	hydroxycholesterol	 or	
25 nM	T0901317	for	24 h	in	serum-	free	culture	medium,	
and	then	challenged	for	2 h	with	control	medium	or	me-
dium	 containing	 pyolysin.	 At	 the	 end	 of	 the	 challenge	
period,	supernatants	were	collected	to	measure	LDH,	and	
cytolysis	evaluated	by	MTT	assay.
To	 determine	 if	 cytoprotection	 extended	 beyond	
cholesterol-	dependent	 cytolysins,	 after	 a	 24-	h	 treatment	
with	vehicle	or	25 ng/ml	27-	hydroxycholesterol,	cells	were	
challenged	for	24 h	with	8 µg/well	S.	aureus	α-	hemolysin,	
without	 further	 treatment.	The	 amount	 and	 duration	 of	
α-	hemolysin	challenge	was	based	on	previous	work,41	and	
preliminary	 experiments	 where	 a	 shorter	 challenge	 did	





2.5	 |	 MTT assay
Cell	 viability	 was	 assessed	 using	 the	 mitochondria-	
dependent	 reduction	 of	 MTT	 (3-	(4,5-	dimethylthiazol-	2-	y
l)-	2,5-	diphenyltetrazolium	bromide,	Merck),	as	described	
and	validated	previously	for	use	in	endometrial	cells	chal-
lenged	 with	 pyolysin.9	 Briefly,	 cells	 were	 incubated	 for	
2  h	 in	 250  µl/well	 serum-	free	 culture	 medium	 contain-
ing	1 mg/ml	MTT.	The	medium	was	then	discarded,	and	
cells	were	lysed	with	300 µl	DMSO	(Merck).	Optical	den-
sity	 (OD570)	 was	 measured	 using	 a	 POLARstar	 Omega	
microplate	 reader	 (POLARstar	 Omega;	 BMG	 Labtech,	
Aylesbury,	UK).
2.6	 |	 Lactate dehydrogenase
Lactate	 dehydrogenase	 was	 quantified	 using	 LDH-	







An	 assay	 mixture	 of	 54  mM	 sodium	 L-	lactate,	 0.66  mM	
2-	p-	iodophenyl-	3-	p-	nitrophenyl	 tetrazolium,	 0.28  mM	
phenazine	methosulfate,	and	1.3 mM	NAD+	(all	Merck)	













We	 measured	 the	 leakage	 of	 potassium	 from	 cells,	 as	
described	 previously.17	 Cells	 were	 seeded	 at	 1.5  ×  105	
cells/well	 in	 6-	well	 culture	 plates	 (TPP),	 and	 once	 70%	
confluent,	 treated	 for	 24  h	 in	 serum-	free	 medium	 con-
taining	 vehicle,	 25  ng/ml	 27-	hydroxycholesterol,	 5  ng/
ml	 25-	hydroxycholesterol,	 25  nM	 T0901317	 or	 125  nM	
GW3965;	 0.5  mM	 methyl-	β-	cyclodextrin	 was	 used	 as	
a	 control	 to	 reduce	 cellular	 cholesterol.32	 The	 super-




and	 then	 incubated	 in	 potassium-	free	 choline	 buffer	
containing	 control	 medium	 or	 pyolysin	 for	 5  min,	 or	 α-	
hemolysin	 for	 15  min.	 Potassium	 was	 measured	 in	 cell	
supernatants	 using	 a	 Jenway	 PFP7	 flame	 photometer	
(Cole-	Parmer,	 Stone,	 UK).	 Inter-	 and	 intra-	assay	 coeffi-
cients	of	variation	were	<4%.






or	 0.5  mM	 methyl-	β-	cyclodextrin.	 The	 cells	 were	 then	
washed	with	PBS,	collected	in	200 µl/well	cholesterol	assay	
buffer,	 and	 cholesterol	 was	 measured	 using	 the	 Amplex	
Red	 Cholesterol	 Assay	 Kit	 (Thermo	 Fisher	 Scientific).	
Total	protein	was	measured	in	the	same	samples	using	a	
DC	protein	assay	(BioRad,	Hercules,	CA,	United	States),	




Phalloidin	 was	 used	 to	 stain	 the	 actin	 cytoskeleton,	 as	
described	previously.17	Briefly,	epithelial	or	stromal	cells	
were	cultured	on	glass	cover	slips	in	complete	medium	to	
70%	 confluency;	 treated	 for	 24  h	 in	 serum-	free	 medium	
containing	 vehicle	 or	 25  ng/ml	 27-	hydroxycholesterol;	
and,	 challenged	 with	 control	 medium	 or	 medium	 con-
taining	 pyolysin	 for	 2  h,	 or	 α-	hemolysin	 for	 24  h.	 The	
cells	 were	 then	 washed	 with	 PBS,	 fixed	 with	 4%	 para-
formaldehyde,	washed	with	PBS,	and	permeabilized	with	
0.2%	 Triton	 X-	100	 (all	 Merck).	 The	 cells	 were	 blocked	
for	 30  min	 in	 PBS	 containing	 0.5%	 bovine	 serum	 albu-
min	(BSA)	and	0.1%	Triton	X-	100,	and	incubated	for	1 h	
with	 Alexa	 Fluor	 555-	conjugated	 phalloidin	 (Thermo	
Fisher	 Scientific).	 Cells	 were	 washed	 with	 0.1%	 Triton	
X-	100	 in	 PBS,	 and	 mounted	 onto	 microscope	 slides	
using	40,6-	diamidino2-	phenylindole	 to	visualize	cell	nu-
clei	 (Vectashield	 with	 DAPI;	 Vector	 Laboratories	 Inc,	
Burlington,	 CA,	 USA).	 The	 cells	 were	 examined	 using	
an	Axio	Imager	M1	fluorescence	microscope	and	images	





Filipin	 III	 from	 Streptomyces filipinensis	 was	 used	 to	
stain	cholesterol,17	using	stromal	cells	because	they	con-
tain	more	cholesterol	than	epithelial	cells.9	Cells	on	glass	
cover	 slips	 were	 treated	 for	 24  h	 in	 serum-	free	 medium	
containing	 vehicle,	 25  ng/ml	 27-	hydroxycholesterol,	
5  ng/ml	 25-	hydroxycholesterol,	 or	 0.5  mM	 methyl-	β-	
cyclodextrin.	Cells	were	washed	with	PBS,	fixed	with	4%	
paraformaldehyde,	 washed	 with	 PBS,	 and	 stained	 with	
50 μg/ml	filipin	III	for	45 min,	before	washing	in	PBS	and	
applying	2.5%	Mowiol	mounting	medium	containing	2.5%	





2.10	 |	 Western blotting
Binding	 of	 pyolysin	 to	 cells	 was	 quantified	 as	 described	
previously.9,11	Stromal	cells	were	seeded	at	1.5 × 105	cells/
well	 in	 6-	well	 plates	 in	 complete	 medium	 for	 24  h,	 and	
then	 treated	 for	 24  h	 in	 serum-	free	 medium	 containing	
vehicle,	50 nM	progesterone,	0.1 nM	estradiol,	10 µM	hy-
drocortisone,	25 ng/ml	27-	hydroxycholesterol	or	0.5 mM	
methyl-	β-	cyclodextrin,	 before	 a	 2-	h	 challenge	 with	 con-
trol	 serum-	free	 medium	 or	 pyolysin.	 Cells	 were	 then	
washed	 with	 300  μl	 ice-	cold	 PBS	 and	 lysed	 with	 100  μl	










Membranes	 were	 then	 washed	 5	 times	 in	 TBST	 and	 in-
cubated	 for	 1  h	 at	 room	 temperature	 with	 1:2500	 dilu-
tion	anti-	rabbit	IgG	(RRID:	AB_2099233;	Cell	Signalling)	
in	 TBST	 5%	 BSA.	 Membranes	 were	 washed	 a	 further	 5	
times	in	TBST,	and	protein	reactivity	was	visualized	using	
enhanced	 chemiluminescence	 (Clarity	 Western	 ECL	
Substrate,	 BioRad).	 Membrane	 images	 were	 captured	
using	 a	 ChemiDoc	 XRS	 System	 (BioRad),	 and	 the	 aver-
age	 peak	 density	 of	 bands	 quantified	 and	 normalized	 to	
α-	tubulin	using	Fiji.43
To	 validate	 siRNA	 targeting	 NR1H2	 and	 NR1H3,	 cell	
lysates	 were	 stored	 in	 PhosphoSafe	 Extraction	 Reagent	
for	 western	 blot	 quantification	 of	 LXRα	 and	 LXRβ,	
and	 ABCA1,	 which	 is	 an	 LXR-	induced	 protein.30	 We	
also	 examined	 whether	 treating	 cells	 with	 25  ng/ml	
27-	hydroxycholeterol	 or	 25  nM	 T0901317	 for	 24  h	 in-
creased	 ABCA1	 abundance.	 Proteins	 were	 separated	
using	 10%	 (LXR)	 or	 7.5%	 (ABCA1)	 SDS-	polyacrylamide	
gel	 electrophoresis,	 as	 descried	 above.	 Membranes	 were	
probed	 with	 antibodies	 for	 LXRα	 (RRID:	 AB_2877144;	
Abcam),	 LXRβ	 (RRID:	 AB_776097;	 Abcam),	 ABCA1	
(RRID:	 AB_444302;	 Abcam,	 Cambridge,	 UK),	 α-	tubulin	
or	β-	actin	(RRID:	AB_306371;	Abcam);	incubated	for	1 h	
with	anti-	mouse	IgG	(RRID:AB_330924;	Cell	Signalling)	
or	 anti-	rabbit	 IgG	 secondary	 antibodies;	 and	 visualized	
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using	enhanced	chemiluminescence.	Average	peak	band	
density	 was	 quantified	 and	 normalized	 to	 β-	actin	 or	 α-	
tubulin	using	Fiji.






(BD	 Medical,	 Oxford,	 UK).	 In	 addition,	 we	 explored	
whether	endometrial	cells	also	secreted	oxysterols	 in	re-
sponse	to	lipopolysaccharide	(LPS)	or	pyolysin,	which	are	










Samples	 were	 extracted	 as	 described	 previously.45,46	
For	 biological	 samples,	 100  µl	 was	 added	 dropwise	
over	 5  min	 to	 1  ml	 ethanol	 containing	 2  ng	 [25,26,26,
26,27,27,27-	2H6]24R/S-	hydroxycholesterol,	 2  ng	 [25,26,
26,26,27,27,27-	2H7]22R-	hydroxycholset-	4-	en-	3-	one,	 and	
400  ng	 [25,26,26,26,27,27,27-	2H7]cholesterol	 (Avanti	
Polar	 Lipids)	 in	 an	 ultrasonic	 bath,	 and	 the	 solution	
was	diluted	 to	give	70%	ethanol.	For	cell	 supernatants,	
1 ml	was	added	dropwise	 to	2.3 ml	ethanol	containing	
the	 same	 standards	 under	 sonication.	 Solutions	 were	
then	 centrifuged	 at	 17  000  g	 for	 30  min	 at	 4°C	 to	 re-
move	 debris.	 Then,	 200-	mg	 Certified	 Sep-	Pak	 C18	 col-
umns	(Waters,	Elstree,	Herts,	UK)	were	used	to	separate	
oxysterols	 and	 steroid	 acids	 from	 cholesterol,	 with	 the	






A	 and	 B	 samples	 were	 incubated	 for	 1  h	 at	 37.5°C	 be-
fore	addition	of	2 ml	absolute	methanol	and	150 µl	gla-
cial	 acetic	 acid.	 Finally,	 150  mg	 [2H0]Girard	 P	 reagent	
(Tokyo	Chemical	Industry,	Oxford,	UK)	was	added	to	all	
samples	 and	 vortexed.	 The	 derivatization	 reaction	 was	
then	 allowed	 to	 occur	 overnight,	 in	 the	 dark,	 at	 room	
temperature,	and	excess	derivatization	reagent	removed	
using	60-	mg	Oasis	HLB	columns	(Waters).	Samples	were	
run	 through	 the	 columns	 3	 times,	 and	 were	 diluted	 to	
35%	and	17.5%	methanol	for	the	second	and	third	time,	
respectively.	The	flow	through	was	discarded	and	sterols	
were	 eluted	 from	 the	 columns	 with	 3  ×  1  ml	 absolute	
methanol	to	give	SPE2-	Fr1-	3	and	1 ml	absolute	ethanol	
(SPE2-	Fr4).	 The	 SPE2	 fractions	 were	 analyzed	 on	 an	
Orbitrap	Elite	(Thermo	Fisher	Scientific)	equipped	with	
an	 electrospray	 probe,	 and	 a	 Dionex	 Ultimate	 3000	 LC	






scan	 events	 in	 the	 linear	 ion	 trap.	 Quantification	 was	
performed	with	Xcalibur	3.0	(Thermo	Fisher	Scientific)	
by	 stable	 isotope	 dilution	 using	 [25,26,26,26,27,27,27-	
2H6]24	R/S-	hydroxycholesterol	as	the	internal	standard;	
where	authentic	standards	were	unavailable,	oxysterols	
were	 identified	 by	 retention	 time,	 mass	 and	 be	 sec-
ond	 generation	 product	 ion	 (MS3)	 spectra.	 Peak	 areas	
were	 used	 to	 calculate	 concentrations,	 as	 described	
previously.46
2.12	 |	 Statistical analysis
The	statistical	unit	was	each	animal	used	to	isolate	cells	
or	 to	 collect	 samples.	 Statistical	 analysis	 was	 performed	
using	 GraphPad	 Prism	 8.4.2	 (GraphPad	 Software,	 San	
Diego,	California,	USA).	Data	are	reported	as	arithmetic	
mean	 (SEM),	 and	 significance	 attributed	 when	 p  <  .05.	





3 	 | 	 RESULTS
3.1	 |	 27- hydroxycholesterol protected 
endometrial cells against pyolysin
To	be	able	to	explore	cytoprotection,	we	first	determined	
the	 amount	 of	 pyolysin	 needed	 to	 damage	 bovine	 en-
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Dunnett's	 multiple	 comparison	 test,	 n  =  4)	 and	 stromal	
cells	(25 HU/well:	p < .001,	n = 4).
To	 examine	 whether	 side-	chain-	hydroxycholesterols	
are	 cytoprotective,	 cells	 were	 treated	 for	 24  h	 in	
serum-	free	 medium	 with	 a	 range	 of	 concentrations	 of	
27-	hydroxycholesterol,	which	is	abundant	in	plasma.33	The	
cells	 were	 then	 challenged	 for	 2  h	 with	 control	 medium	
or	 pyolysin,	 without	 further	 treatment.	 Pyolysin	 caused	
leakage	of	LDH,	and	cytolysis	as	expected,	but	 treatment	
with	 27-	hydroxycholesterol	 reduced	 pyolysin-	induced	
leakage	of	LDH	and	cytolysis	in	epithelial	cells	(Figure 1C)	
and	 stromal	 cells	 (Figure  1D).	 Specifically,	 25  ng/ml	
27-	hydroxycholesterol	 reduced	 epithelial	 and	 stromal	 cell	
pyolysin-	induced	leakage	of	LDH	by	56%	and	82%,	respec-
tively	(p < .001,	two-	way	ANOVA	with	Dunnett's	multiple	
comparison	 test),	 and	 reduced	 pyolysin-	induced	 cytol-
ysis	 from	>60%	to	<5%	and	<15%,	respectively	(p <  .05).	
The	 use	 of	 a	 control	 challenge	 (Figure  1C,D;	 grey	 bars)	
showed	 that	 27-	hydroxycholesterol	 did	 not	 significantly	
alter	 the	 leakage	of	LDH	(p >  .99)	or	cell	viability	per	se	
(p  >  .63).	 In	 an	 independent	 experiment,	 cytoprotection	
against	pyolysin	was	evident	after	8 h	treatment	of	epithe-
lial	cells	 (p <  .001,	Figure 1E)	or	stromal	cells	 (p =  .017,	
Figure 1F),	and	for	both	cell	types	viability	was	correlated	







To	 examine	 whether	 27-	hydroxycholesterol	 also	 pro-
tected	 cells	 against	 changes	 in	 cell	 shape	 or	 the	 actin	
cytoskeleton,	 cells	were	 stained	with	phalloidin.17	A	2-	h	
challenge	with	pyolysin	altered	the	shape	of	epithelial	and	
stromal	 cells,	 reduced	 the	 definition	 of	 actin	 fibers,	 and	
the	 cytoskeleton	 collapsed	 in	 some	 cells	 (Figure  1G,H).	
However,	 treatment	 with	 27-	hydroxycholesterol	 reduced	
pyolysin-	induced	cytoskeletal	changes	compared	with	ve-
hicle	 in	epithelial	 cells	 (22 ± 2%	vs.	99 ± 1%	cells	dam-
aged,	t-	test,	n = 3,	p < .01)	and	stromal	cells	(30 ± 9%	vs.	
77 ± 8%	cells	damaged,	n = 4,	p < .01).
3.2	 |	 Oxysterols protected endometrial 
cells against pyolysin
To	 explore	 whether	 cytoprotection	 against	 pyolysin	
extended	 to	 another	 side-	chain-	hydroxycholesterol,	
we	 treated	 endometrial	 cells	 with	 a	 range	 of	 concen-
trations	 of	 25-	hydroxycholesterol,	 followed	 by	 a	 2-	h	
challenge	 with	 control	 medium	 or	 pyolysin	 (Figure	
2A,B).	 Although	 in	 the	 control	 challenge	 50  ng/ml	
25-	hydroxycholesterol	 reduced	 stromal	 cell	 viability	 by	
37%	 (Figure  2B,	 grey	 bars,	 p  <  .001),	 lower	 concentra-
tions	of	25-	hydroxycholesterol	did	not	significantly	alter	
cell	 viability	 (Figure  2B,	 grey	 bars,	 p  =  .91).	 More	 im-
portantly,	 treating	 epithelial	 or	 stromal	 cells	 for	 24  h	
with	 25-	hydroxycholesterol	 reduced	 pyolysin-	induced	
LDH	 leakage	 and	 cytolysis	 in	 epithelial	 (Figure  2A)	
and	 stromal	 cells	 (Figure  2B).	 Specifically,	 5  ng/ml	
25-	hydroxycholesterol	 reduced	 pyolysin-	induced	 LDH	
leakage	by	84%	and	79%	in	epithelial	and	stromal	cells,	
respectively	(p < .001,	two-	way	ANOVA	with	Dunnett's	
multiple	 comparison	 test),	 and	 reduced	 cytolysis	 from	
>60%	to	<5%	and	<25%,	respectively	(p < .01).
To	evaluate	whether	the	side-	chain-	hydroxycholesterols	
also	 protected	 against	 the	 initial	 formation	 of	 pores	 in	







pyolysin	 challenge,	 and	 methyl-	β-	cyclodextrin	 reduced	
pyolysin-	induced	 leakage	of	potassium	from	stromal	but	
not	 epithelial	 cells	 (Figure  2C,D).	 However,	 treatment	
with	 27-	hydroxycholesterol	 or	 25-	hydroxycholesterol	 re-
duced	 pyolysin-	induced	 leakage	 of	 potassium	 from	 both	
epithelial	(p < .05,	Figure 2C)	and	stromal	cells	(p < .001,	
Figure 2D).
To	 test	 whether	 the	 cytoprotection	 against	 pyoly-
sin	 persisted	 beyond	 a	 2-	h	 challenge,	 we	 treated	 cells	
with	 vehicle,	 25  ng/ml	 27-	hydroxycholesterol	 or	 5  ng/ml	
25-	hydroxycholesterol	for	24 h,	and	then	challenged	the	cells	
with	pyolysin	for	another	24 h,	without	further	treatment.	






One	 consideration	 was	 whether	 cytoprotection	
might	 be	 an	 artifact	 of	 pyolysin	 binding	 to	 side-	chain-	
hydroxycholesterols.	 However,	 mixing	 pyolysin	 with	
27-	hydroxycholesterol	 or	 25-	hydroxycholesterol	 and	 then	
challenging	 untreated	 cells	 did	 not	 significantly	 diminish	
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3.3	 |	 Steroid hormones do not protect 
endometrial cells against pyolysin
We	 examined	 whether	 cholesterol-	derived	 steroid	 hor-




centrations	 of	 oxysterols,	 micromolar	 concentrations	 of	
27-	hydroxycholesterol	 or	 25-	hydroxycholesterol	 can	 also	










3.4	 |	 Oxysterols reduced pyolysin 
binding and cytolysin- accessible 
cholesterol in cell membranes








27-	hydroxycholesterol	 or	 25-	hydroxycholesterol	 did	 not	
significantly	 alter	 the	 abundance	 of	 cholesterol	 in	 epithe-





compared	 with	 vehicle	 (Figure  4C,D).	 However,	 although	
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there	was	increased	staining	surrounding	the	nucleus,	there	
was	no	significant	effect	of	27-	hydroxycholesterol	(p = .98)	
or	 25-	hydroxycholesterol	 (p  =  .39)	 on	 filipin	 III	 cellular	
fluorescence.
As	 cells	 can	 take	 up	 cholesterol	 from	 lipoproteins	 in	
serum,52	we	considered	 the	possibility	 that	serum	might	
alter	 the	 protective	 role	 of	 the	 oxysterols.	 Therefore,	
cells	 were	 treated	 with	 either	 27-	hydroxycholesterol	 or	
25-	hydroxycholesterol	 in	 culture	 medium	 containing	
10%	 serum	 for	 24  h,	 and	 then	 challenged	 with	 pyolysin	
for	2 h.	As	serum	contains	LDH,53	it	was	not	possible	to	




As	 cholesterol-	dependent	 cytolysins	 specifically	 bind	
accessible	 cholesterol	 in	 cell	 membranes,12–	14	 we	 mea-
sured	 the	 binding	 of	 pyolysin	 to	 cells.	 We	 used	 stromal	
cells	 because	 they	 have	 more	 cholesterol	 than	 epithelial	
cells	(Figure 4A,B).	Treatment	with	methyl-	β-	cyclodextrin	
reduced	 pyolysin	 binding	 by	 85%,	 compared	 with	 vehi-
cle,	and	27-	hydroxycholesterol	 reduced	pyolysin	binding	
by	 65%	 (Figure  4G).	 Cytolysin-	accessible	 cholesterol	 in	
cell	membranes	can	be	depleted	with	little	effect	on	total	
cellular	cholesterol,	by	activating	ACAT	esterification	of	
cholesterol	 with	 hydroxycholesterols,	 but	 not	 with	 syn-
thetic	 LXR	 agonists.27,28	 To	 determine	 whether	 ACAT	
contributed	 to	 cytoprotection,	 cells	 were	 treated	 with	
the	ACAT	inhibitor	SZ58-	035	for	16 h,	followed	by	SZ58-	
035	 for	a	 further	24 h	with	27-	hydroxycholesterol	or	 the	
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synthetic	LXR	agonist	T0901317,	and	then	a	2-	h	pyolysin	
challenge.	As	expected,	T0901317	cytoprotection	was	not	
significantly	 affected	 by	 the	 ACAT	 inhibitor.	 However,	
SZ58-	035	 diminished	 27-	hydroxycholesterol	 cytoprotec-
tion	against	pyolysin-	induced	LDH	leakage	and	cytolysis	
(Figure 4H,I).	Taken	together,	these	data	provide	evidence	
that	 27-	hydroxycholesterol	 cytoprotection	 against	 pyoly-
sin	was	at	least	partially	dependent	on	reducing	cytolysin-	
accessible	cholesterol	in	cell	membranes.
3.5	 |	 Oxysterol cytoprotection depends 
partly on liver X receptors
We	 next	 examined	 the	 role	 of	 LXRs	 in	 cytoprotection	
because	 side-	chain-	hydroxycholesterols	 are	 ligands	 for	
LXRα	and	LXRβ.25	Our	 first	 approach	used	 synthetic	 li-
gands	for	both	LXRα	and	LXRβ,	T0901317	and	GW3965,	
which	 are	 structurally	 unrelated	 to	 oxysterols,25,35–	37	
and	 do	 not	 bind	 to	 pyolysin	 (Supporting	 Information	
Figure	 S2).	 Cells	 were	 treated	 for	 24  h	 with	 T0901317	
or	 GW3965,	 and	 then	 challenged	 with	 pyolysin	 for	
2  h.	 In	 epithelial	 cells,	 T0901317	 and	 GW3965	 reduced	
pyolysin-	induced	LDH	leakage	by	up	to	25%	and	33%,	re-
spectively	 (Figure  5A,	 p  <  .01	 and	 p  <  .05),	 but	 not	 cy-
tolysis	 (p =  .13	and	p =  .24).	 In	stromal	cells,	T0901317	






tassium	 leakage	 from	 epithelial	 cells	 (Figure  5C),	 they	
tended	 to	 reduced	 potassium	 leakage	 from	 stromal	 cells	
(Figure 5D,	p = .07).	The	cytoprotective	concentrations	of	
25 ng/ml	(62 nM)	27-	hydroxycholeserol,	50 nM	T0901317	
and	 250  nM	 GW3965	 were	 similar	 to	 reported	 EC50	 for	
LXRα	of	85,	85	and	190 nM,	 respectively.35,37,54	 In	addi-
tion,	25 ng/ml	27-	hydroxycholeserol	and	25 nM	T0901317	
increased	 the	 abundance	 of	 the	 LXR-	dependent	 protein	
ABCA1	in	epithelial	and	stromal	cells	(Figure 5E,F).
Our	 second	 approach	 was	 to	 knockdown	 LXRα	 and	
LXRβ	 by	 transfecting	 epithelial	 and	 stromal	 cells	 with	
previously	validated	siRNA	targeting	NR1H3	and	NR1H2,	
respectively.32	Additional	validation	in	the	present	study	
showed	 that	 siRNA	 targeting	 NR1H3	 and	 NR1H2	 re-
duced	 LXRα	 and	 LXRβ	 protein	 abundance,	 and	 the	
abundance	 of	 ABCA1	 (Supporting	 Information	 Figure	
S5).	Cells	were	transfected	with	siRNA	targeting	NR1H3	
and	 NR1H2,	 independently	 and	 in	 combination,	 be-
fore	 treatment	with	27-	hydroxycholesterol	or	T0901317	
for	 24  h,	 followed	 by	 a	 2-	h	 challenge	 with	 pyolysin.	
Targeting	 both	 NR1H3	 and	 NR1H2	 diminished	 the	
27-	hydroxycholesterol	 cytoprotection	 against	 pyolysin-	






pyolysin	 in	 epithelial	 and	 stromal	 cells	 (Supporting	
Information	Figure	S6).	Collectively,	these	data	provide	
evidence	that	side-	chain-	hydroxycholesterol	cytoprotec-
tion	 against	 pyolysin	 is	 at	 least	 partially	 dependent	 on	
LXRα	and	LXRβ.
3.6	 |	 Oxysterols protected cells against 
α- hemolysin
To	 determine	 whether	 cytoprotection	 extended	 be-
yond	 pyolysin,	 we	 treated	 cells	 with	 vehicle	 or	 25  ng/
ml	 27-	hydroxycholesterol,	 and	 then	 challenged	 the	
cells	with	S. aureus	α-	hemolysin	 for	24 h,	without	 fur-





α-	hemolysin-	induced	 leakage	 of	 LDH	 and	 cytolysis.	
Although	 potassium	 leakage	 was	 not	 detected	 from	
epithelial	 cells	 following	 a	 15-	min	 α-	hemolysin	 chal-
lenge	 (Figure  7C),	 27-	hydroxycholesterol	 reduced	 α-	






these	 data	 provide	 evidence	 for	 27-	hydroxycholesterol	
cytoprotection	 of	 endometrial	 cells	 against	 S. aureus	
α-	hemolysin.
3.7	 |	 Endometrial cells released  
oxysterols
To	better	understand	the	biological	relevance	of	oxyster-
ols	 in	 the	bovine	reproductive	 tract,	we	used	mass	spec-
trometry	and	 found	a	range	of	oxysterols	 in	uterine	and	
ovarian	 follicular	 fluid	 (Table  1,	 Figure  8A).	 Notably,	
27-	hydroxycholesterol	 and	 25-	hydroxycholesterol	 were	
detected	 in	 uterine	 fluid,	 as	 well	 as	 the	 metabolite	 of	
25-	hydroxycholesterol,	 7α,25-	hydroxycholesterol.	 As	
ovarian	 steroids	 regulate	 endometrial	 function,47	 it	 was	
interesting	 that	 there	 were	 higher	 concentrations	 of	
   | 13 of 21ORMSBY et al.
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oxysterols	 in	ovarian	 follicular	 fluid	collected	 from	both	
growing	and	dominant	follicles	than	in	uterine	fluid.
We	 next	 considered	 whether	 endometrial	 cells	
might	 also	 secrete	 oxysterols	 in	 response	 to	 a	 sub-	lytic	
amount	 of	 5  HU	 pyolysin	 for	 24  h.	 We	 used	 1  µg/ml	
LPS	 as	 a	 control	 because	 it	 is	 a	 major	 virulence	 factor	
of	 uterine	 pathogens44;	 and,	 because	 LPS	 stimulates	
the	 release	 of	 25-	hydroxycholesterol	 from	 murine	 mac-
rophages.29	 Few	 oxysterols	 were	 detectable	 in	 serum-	
free	 culture	 medium	 (Table  2).	 However,	 epithelial	 cell	
supernatants	 contained	 several	 oxysterols,	 including	
25-	hydroxycholesterol	(Figure 8B,C),	and	concentrations	
of	 25-	hydroxycholesterol	 increased	 by	 220%	 following	
pyolysin	challenge.	The	supernatants	of	stromal	or	epi-
thelial	cells	had	no	detectable	27-	hydroxycholesterol,	and	
25-	hydroxycholesterol	 was	 barely	 detectable	 in	 stromal	
cells	 (Figure 8D).	Together	 these	data	provide	evidence	
for	 oxysterols	 in	 the	 reproductive	 tract,	 and	 the	 release	
of	25-	hydroxycholesterol	from	epithelial	cells	challenged	
with	pyolysin.
4 	 | 	 DISCUSSION
In	this	study	we	discovered	that	both	27-	hydroxycholesterol	
and	25-	hydroxycholesterol	increased	the	intrinsic	protec-
tion	 of	 bovine	 endometrial	 cells	 against	 pore-	forming	
toxins	 from	 uterine	 pathogens.	 Treating	 epithelial	 or	
stromal	cells	with	the	side-	chain-	hydroxycholesterols	re-
duced	the	formation	of	pyolysin-	induced	cell	membrane	
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pores	and	protected	cells	against	damage.	This	oxysterol	









as	 determined	 by	 the	 leakage	 of	 potassium	 and	 LDH,	
caused	 cell	 damage	 as	 determined	 by	 changes	 in	 cell	
shape	 and	 the	 cytoskeleton,	 and	 reduced	 cell	 viability.	
These	effects	are	typical	of	cholesterol-	dependent	cytol-
ysins,	which	are	the	most	common	pore-	forming	toxins	
secreted	 by	 pathogenic	 bacteria.7,15,16,22	 Endometrial	
cells	 were	 also	 damaged	 by	 α-	hemolysin,	 but	 the	 cells	
required	 a	 longer	 challenge	 than	 for	 pyolysin,	 which	
might	 reflect	 the	 ten-	fold	 smaller	 pore	 diameter	 of	 α-	
hemolysin	 than	 pyolysin.7,15,20	 Epithelial	 cells	 were	
less	susceptible	 than	stromal	cells	 to	damage	by	either	
toxin,	which	supports	the	concept	of	a	resilient	epithe-
lium	helping	 tissues	 to	 tolerate	pathogens.3,9	However,	




Our	 most	 striking	 finding	 was	 that	 the	 side-	
chain-	hydroxycholesterols	 27-	hydroxycholesterol	 or	
25-	hydroxycholesterol,	 but	 not	 the	 ring-	modified-	




with	 25  ng/ml	 27-	hydroxycholesterol	 or	 5  ng/ml	
25-	hydroxycholesterol	also	reduced	the	leakage	of	potas-
sium	and	LDH,	and	limited	pyolysin-	induced	changes	in	































persisted	 for	at	 least	24 h.	Our	 findings	 support	 recent	
observations	that	murine	macrophages	stimulated	with	
interferon	 are	 protected	 against	 cholesterol-	dependent	
cytolysins	 perfringolysin	 O,	 streptolysin	 O	 and	 an-




also	 protected	 endometrial	 cells	 against	 α-	hemolysin,	








22R-	hydroxycholesterol 0.2 ± 0.2 2.3 ± 0.8 2.4 ± 1.5
24S-	hydroxycholesterol 0.2 ± 0.2 0.2 ± 0.1 0.5 ± 0.1
25-	hydroxycholesterol 3.9 ± 0.6 13.4 ± 10.5 26.8 ± 11.4
25-	hydroxycholest-	4-	en-	3-	one 0.0 ± 0.0 0.1 ± 0.1 2.1 ± 1.8
27-	hydroxycholesterol 19.9 ± 4.9 104.3 ± 69.7 244.6 ± 99.5
27-	hydroxycholest-	4-	en-	3-	one 0.0 ± 0.0 0.5 ± 0.2 6.8 ± 5.2
7β-	hydroxycholesterol 0.8 ± 0.8 0.4 ± 0.2 0.4 ± 0.2
7α-	hydroxycholesterol 8.3 ± 4.9 0.9 ± 0.6 1.1 ± 0.0
7α-	hydroxycholest-	4-	en-	3-	one 17.0 ± 8.4 0.2 ± 0.1 1.3 ± 1.1
6β-	hydroxycholesterola	 7.1 ± 0.9 2.3 ± 0.6 2.2 ± 0.2
6β-	hydroxycholest-	4-	en-	3-	onea	 0.8 ± 0.5 0.2 ± 0.1 0.9 ± 0.6
7-	oxocholesterol 13.2 ± 1.5 2.8 ± 1.0 6.8 ± 5.1
24,25-	epoxycholesterol 0.6 ± 0.6 7.5 ± 4.9 9.3 ± 7.3
24,25-	epoxycholest-	4-	en-	3-	one 0.0 ± 0.0 0.3 ± 0.2 6.6 ± 5.3
24,27-	dihydroxycholesterol 0.5 ± 0.5 5.8 ± 3.0 4.8 ± 3.0
24,27-	dihydroxycholest-	4-	en-	3-	one 0.0 ± 0.0 0.3 ± 0.2 2.6 ± 2.3
7α,25-	dihydroxycholesterol 1.3 ± 0.7 0.7 ± 0.4 2.0 ± 1.5
7α,25-	dihydroxycholest-	4-	en-	3-	one 1.5 ± 0.4 1.5 ± 0.5 16.7 ± 12.6
7α,27-	dihydroxycholesterol 0.0 ± 0.0 0.2 ± 0.2 0.0 ± 0.0
7α,27-	dihydroxycholest-	4-	en-	3-	one 2.3 ± 0.7 1.3 ± 0.2 13.8 ± 6.4
3β,7β-	dihydroxycholest-	5-	en-	26-	oic	acid 0.0 ± 0.0 2.3 ± 0.2 2.0 ± 1.0
7β-	hydroxy-	3-	oxocholest-	4-	en-	26-	oic	acid 0.0 ± 0.0 0.3 ± 0.17 0.5 ± 0.2
3β,7α-	dihydroxycholest-	5-	en-	26-	oic	acid 4.9 ± 2.5 13.2 ± 6.9 6.5 ± 4.2
7α-	hydroxy-	3-	oxocholest-	4-	en-	26-	oic	acid 81.3 ± 20.0 76.8 ± 21.0 258.9 ± 136.8
3β,22R-	dihydroxycholest-	5-	en-	26-	oic	acid 0.0 ± 0.0 23.5 ± 14.7 23.9 ± 13.5
22R-	hydroxy-	3-	oxocholest-	4-	en-	26-	oic	acid 0.0 ± 0.0 3.0 ± 1.6 11.1 ± 4.7
20R,22R,25-	trihydroxycholesterol 0.9 ± 0.9 10.7 ± 5.5 2.4 ± 1.8
20R,22R,25-	trihydroxycholest-	4-	en-	3-	one 1.1 ± 0.8 2.4 ± 0.7 39.5 ± 21.3
7α,24,25-	trihydroxycholest-	4-	en-	3-	one 4.8 ± 2.5 4.3 ± 1.3 20.5 ± 13.2
3β-	hydroxycholest-	5-	enoic	acid 12.7 ± 6.8 283.3 ± 249.4 295.8 ± 118.4
3-	oxocholest-	4-	enoic	acid 4.4 ± 3.1 20.8 ± 12.9 11.1 ± 4.7
3β,7α,24-	trihydroxycholest-	5-	en-	26-	oic	acid 0.0 ± 0.0 0.57 ± 0.57 0.0 ± 0.0
7α,24-	dihydroxy-	3-	oxocholest-	4-	en-	26-	oic	acid 3.6 ± 1.8 5.1 ± 0.2 16.4 ± 6.8
3β,7α,25-	trihydroxycholest-	5-	en-	26-	oic	acid 0.0 ± 0.0 0.8 ± 0.6 1.5 ± 0.9









of	 these	oxysterols	 is	yet	 to	be	resolved.	While	much	re-
mains	to	be	discovered	about	oxysterols	in	the	female	gen-
ital	 tract	 of	 cattle,	 we	 found	 both	 27-	hydroxycholesterol	
and	 25-	hydroxycholesterol	 in	 uterine	 fluid	 and	 ovarian	
F I G U R E  8  Oxysterols	in	the	bovine	reproductive	tract.	Chromatographic	separation	(m/z	534.4054 ± 5 ppm)	of	indicated	oxysterols	
from	(A)	dominant	ovarian	follicular	fluid	sample	derivatized	with	[2H0]	Girard	P	reagent,	and	(B)	supernatant	of	epithelial	cells	challenged	
for	24 h	with	5	HU	pyolysin.	Concentrations	of	selected	oxysterols	in	supernatants	from	epithelial	(C)	and	stromal	cells	(D)	challenged	for	
24 h	with	control	medium	( ),	or	medium	containing	1 µg/ml	LPS	( )	or	5	HU	pyolysin	( ).	Data	are	presented	as	mean	(SEM)	using	cells	
from	3	independent	animals;	statistical	significance	is	determined	using	two-	way	ANOVA	and	Dunnett's	multiple	comparison	post	hoc	test,	
with	p-	values	reported	for	difference	from	control
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follicular	 fluid,	 and	 endometrial	 epithelial	 cells	 also	 re-
leased	 25-	hydroxycholesterol.	 Notably,	 endometrial	 cells	
did	 not	 release	 27-	hydroxycholesterol,	 which	 indicates	
that	 endometrial	 cells	 were	 not	 the	 origin	 of	 this	 oxys-
terol	in	the	biological	fluids.	However,	the	concentrations	
of	 27-	hydroxycholesterol	 and	 25-	hydroxycholesterol	 we	
measured	 in	 uterine	 fluid	 were	 similar	 to	 the	 concen-
trations	 we	 used	 to	 treat	 endometrial	 cells.	 Although	
the	innate	immune	response	to	LPS	triggers	secretion	of	
25-	hydroxycholesterol	 from	 macrophages,6,29	 we	 unex-
pectedly	 found	 that	 pyolysin	 also	 stimulated	 the	 secre-
tion	of	25-	hydroxycholesterol.	We	suggest	 that	epithelial	
cells	 might	 release	 25-	hydroxycholesterol	 to	 help	 pro-
tect	 stromal	 cells	 against	 pore-	forming	 toxins.	 This	 ox-
ysterol	 cytoprotection	 would	 add	 to	 the	 existing	 role	
for	 oxysterols	 in	 regulating	 immunity	 to	 pathogens.4–	6	
Steroids	 also	 modulate	 defenses	 against	 pathogens	 in	
the	 uterus,	 with	 estradiol	 reducing	 the	 risk	 of	 disease,	
and	progesterone	and	hydrocortisone	increasing	the	risk	
of	 disease.47–	49	 However,	 in	 the	 present	 study,	 estradiol,	
progesterone,	and	hydrocortisone	did	not	alter	pyolysin-	
induced	 leakage	of	LDH	or	cytolysis.	There	was	also	no	
evidence	 that	 27-	hydroxycholesterol	 cytoprotection	 was	









pool,	 and	 a	 pool	 of	 cholesterol	 accessible	 to	 cholesterol-	
dependent	 cytolysins.13,14	 Only	 cytolysin-	accessible	 cho-
lesterol	in	cell	membranes	is	“labile”,	and	small	changes	
in	 cholesterol	 synthesis,	 uptake,	 efflux	 or	 metabolism	
markedly	 alter	 cholesterol-	dependent	 cytolysins	 binding	
to	cells.13,14,28	In	the	present	study,	27-	hydroxycholesterol	
reduced	 pyolysin	 binding	 to	 cells,	 even	 though	 the	 ox-
ysterols	 did	 not	 significantly	 alter	 total	 cellular	 choles-
terol.	 Our	 findings	 agree	 with	 recent	 observations	 that	
27-	hydroxycholesterol	 and	 25-	hydroxycholesterol	 reduce	
binding	of	anthrolysin	O	to	cells,	without	reducing	total	
cellular	 cholesterol.28,55	 The	 oxysterols	 were	 thought	 to	
have	 reduced	 cytolysin-	accessible	 cholesterol	 in	 the	 cell	
membrane	 by	 limiting	 cholesterol	 biosynthesis	 or	 ac-
tivating	 ACAT	 esterification	 of	 cholesterol.28,55	 In	 the	
present	 study,	 an	 ACAT	 inhibitor	 also	 diminished	 oxys-
terol	 cytoprotection	 against	 pyolysin.	 However,	 we	 ad-
ditionally	 found	 that	 targeting	 both	 NR1H3	 and	 NRIH2	
with	 siRNA	 diminished	 oxysterol	 cytoprotection	 against	
pyolysin.	 Furthermore,	 synthetic	 LXR	 ligands	 reduced	
pyolysin-	induced	 leakage	 of	 LDH	 from	 stromal	 cells	
by	≥70%;	 almost	 as	 effectively	 as	 the	≥80%	 reduction	 by	
27-	hydroxycholesterol	 or	 25-	hydroxycholesterol.	 Our	 ob-




tection	 partially	 depended	 on	 ACAT	 and	 LXRs,	 they	
likely	 provide	 cytoprotection	 via	 more	 than	 just	 these	
mechanisms.	 Oxysterol-	accelerated	 degradation	 of	
3-	hydroxy-	3-	methylglutaryl	CoA	reductase,56	which	is	the	
rate-	limiting	 enzyme	 in	 cholesterol	 biosynthesis,	 might	
also	contribute	to	reductions	in	cytolysin-	accessible	cho-
lesterol.	 Consistent	 with	 this	 potential	 mechanism,	 we	
have	 shown	 previously	 that	 statins	 or	 siRNA	 targeting	
3-	hydroxy-	3-	methylglutaryl	 CoA	 reductase	 partially	 pro-
tects	 bovine	 endometrial	 epithelial	 cells	 against	 pyoly-
sin.57	 The	 action	 of	 oxysterols	 might	 also	 be	 integrated	
with	the	multiple	complementary	cell	repair	mechanisms	
activated	by	cytolysins.9,16,22,23,31,58	For	example,	oxysterols	
stimulate	 increased	 cytosolic	 calcium,	 which	 could	 acti-
vate	 protective	 repair	 mechanisms	 such	 as	 endocytosis,	
membrane	 blebbing,	 caspase	 activity,	 and	 the	 unfolded	
protein	 response.16,23,58,59	 Further	 work	 is	 required	 to	
establish	whether	 these	mechanisms	contribute	 to	oxys-
terol	 cytoprotection.	 As	 side-	chain-	hydroxycholesterols	











oxysterols	 protected	 against	 α-	hemolysin,	 which	 is	 less	
dependent	 on	 cytolysin-	accessible	 cholesterol	 in	 the	 cell	
membrane	than	pyolysin.7,21
In	 conclusion,	 we	 found	 that	 side-	chain-	
hydroxycholesterols	 increased	 endometrial	 cell-	intrinsic	
protection	against	pore-	forming	toxins.	It	was	striking	that	
both	 27-	hydroxycholesterol	 and	 25-	hydroxycholesterol	
protected	epithelial	and	stromal	cells	against	both	pyoly-
sin	and	α-	hemolysin.	The	oxysterol	cytoprotection	against	
pyolysin	 included	 ACAT	 and	 LXR	 dependent	 mecha-
nisms.	We	also	found	the	side-	chain-	hydroxycholesterols	
in	 uterine	 and	 ovarian	 fluids,	 and	 that	 epithelial	 cells	
released	 25-	hydroxycholesterol	 in	 response	 to	 pyoly-
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